How iron needs change around menopause?
There is a particular bottle that sits in a lot of kitchens. It was bought during a stretch of heavy periods, or handed over by a mother who worried her daughter looked pale, and it has been part of the morning routine ever since.
Then the periods stop. And nobody tells you what to do with the bottle.
This is one of the few places in nutrition where the answer really does change with a life stage — not by a little, but by a lot. Your iron needs after menopause are not a softer version of what they were before. They are a different number entirely. What follows is the shape of that change, what happens in the years leading up to it, and what to bring to your doctor rather than decide alone.
Why your iron needs drop the year your periods stop
Because monthly blood loss was the reason the number was high in the first place.
Every guideline body that sets reference intakes arrives at the same conclusion by the same route, which is unusual and worth noticing. Korea’s 2025 reference intakes set the recommended amount for women aged 19–49 at 12 mg a day, then drop it to 7 mg for women aged 50–64 and 6 mg from 65[1]. The United States goes from 18 mg down to 8 mg at age 51[2]. The European authority decided that once menstruation ends, the figures for women should simply be the same as those for men, and set both at 11 mg[3].
[Table 1] Reference iron intakes before and after menopause, three authorities · Source: KDRIs 2025[1]; NIH ODS[2]; EFSA[3]
| Authority | Before | After | Upper limit |
| Korea (KDRIs 2025) | 12 mg | 7 mg (50–64) | 45 mg |
| United States (NIH ODS) | 18 mg | 8 mg (51+) | 45 mg |
| European Union (EFSA) | 16 mg | 11 mg | not set |
The three columns disagree on the starting figure because they model menstrual losses differently, but on the direction they agree entirely: iron needs fall, and they fall by roughly a third to a half. Korea’s postmenopausal figure is the lowest of the three — and notably, it is lower than the figure Korea sets for adult men, which is 8 mg[1].
The years before that, when the bleeding got heavier
Here is the part I had wrong, and I suspect I am not alone.
I had pictured this as a clean step down: periods stop, requirement falls, done. But the transition into menopause often runs the other way first. Cycles become irregular and, for many women, heavier before they stop altogether. During those years, iron losses can be larger than they were at forty, not smaller — while the supplement aisle is already starting to sell you “50+” formulas with the iron taken out.
So the honest shape of iron needs across this decade is a rise, then a drop. Which of the two you are in matters more than your age on paper.
Where you are in the transition
Your age on paper matters less than which of these three lines you are on.
Note — the third line is not about iron. Bleeding after twelve period-free months warrants evaluation, whatever the cause turns out to be.
Your periods have changed →
The third line is the one to sit with. Bleeding after menopause always warrants evaluation, whatever the eventual cause turns out to be — most causes are benign, with tissue thinning accounting for roughly 60% of cases and polyps about 30%, but the assessment is what establishes that[4]. Taking an iron supplement because you are losing blood again is treating a symptom whose origin has not been looked at.
Standing at the pharmacy shelf in Korea
The label will tell you, but you have to turn the box over.
In Korea, supplements carrying the health functional food (건강기능식품) mark declare each nutrient as a percentage of the Korean daily value, not the US one. A product showing “100%” for iron is built against a different denominator than the American bottle you may be used to reading. And because Korean figures for women over 50 are among the lowest internationally, a general multivitamin formulated for adults can deliver several times what a postmenopausal woman’s iron needs are assumed to be. That is still far below the 45 mg upper limit. But it is no longer the small top-up it looks like.
When the blood panel comes back
Two numbers do most of the work, and they answer different questions.
Haemoglobin tells you whether your blood is currently carrying enough oxygen. Ferritin — a storage protein that reflects how much iron the body has banked — tells you what is left in reserve. Reserves empty before the blood count moves, which is why a normal haemoglobin result does not settle the question on its own.
The World Health Organization puts the deficiency threshold for adults at a ferritin below 15 µg/L, or below 70 µg/L when infection or inflammation is present, because inflammation pushes the reading up regardless of true stores. The same table flags possible iron excess above 150 µg/L in women and 200 µg/L in men[5]. US clinical practice sits a little more conservatively, treating values under 30 µg/L as suggestive of deficiency[2].
That upper flag matters more after menopause than before it. Korean data show the pattern plainly. In a national survey sample, ferritin levels were higher after menopause. Postmenopausal women in the highest third of ferritin had about 1.6 times the odds of meeting metabolic syndrome criteria compared with the lowest — an association not seen in premenopausal women[6]. A separate national survey analysis found the risk of iron depletion was lower in postmenopausal than premenopausal women[7]. Neither study shows that stored iron causes anything. They show that the direction of concern flips.
The genetic framing that dominates English-language writing on iron overload may not transfer. Most hereditary haemochromatosis in Western populations traces to a variant called C282Y. When researchers genotyped 502 unrelated Korean individuals, the variant was not found in a single one[8]. That does not mean stored iron is irrelevant here — the survey findings above were measured in Koreans. It means the risk arrives by a different road, through intake and inflammation rather than an inherited gene, and that a family history of haemochromatosis is a far less likely explanation for a high reading.
Before you pass the bottle to someone else
This is where good intentions need a second look.
Iron is one of the clearer cases where a supplement that suits one person is a poor fit for the next. A man of the same age has never had the menstrual losses that set the higher figure, so his iron needs were never on that curve at all. That is exactly why Korea, the US and the EU all converge on a low number for him. Passing along a leftover bottle of something bought for heavy periods is not a neutral gesture.
Tolerability is the other half. Reports filed with the US adverse event system for products whose brand name contains “iron” are dominated by digestive complaints. Note the word used here. These are events suspected of being linked to a product by whoever filed the report; causality is not established, the system cannot be used to estimate how often anything happens, and manufacturers report under obligation while consumers and clinicians report voluntarily.
[Table 2] Most frequently reported terms across 802 CAERS reports from female consumers, products whose brand name contains “iron”; upper- and mixed-case variants combined; data as of 7 July 2026 · Source: openFDA CAERS API[9]
| Reported term | Reports |
| Diarrhoea | 118 |
| Vomiting | 109 |
| Nausea | 71 |
| Dyspnoea | 60 |
| Abdominal pain | 51 |
| Alopecia | 50 |
| Abdominal pain, upper | 48 |
The digestive cluster at the top is what oral iron is known for. The two non-digestive entries are a reminder of the search’s limits — matching on brand names pulls in products that have nothing to do with iron, and misses iron products that do not carry the word.
What to take to your next appointment
Bring the bottle and bring the dates.
The useful information is not “should I take iron” but the four things a clinician cannot guess: when your last period was, whether bleeding has changed or returned, what you are currently taking and at what elemental dose, and what your last ferritin and haemoglobin readings were. That turns a yes-or-no question into a decision someone can actually make with you.
And if nobody has measured your ferritin, that is worth asking about directly — particularly if you are still in the transition, still bleeding, and have quietly assumed that being “nearly there” means your iron needs have already fallen.
Key Terms
- Ferritin — a protein that reflects how much iron the body has stored. Closer to a fuel gauge than a fuel reading.
- Recommended intake (RNI/RDA) — the daily amount judged to meet the needs of nearly everyone in a group. A target, not a threshold.
- Tolerable Upper Intake Level — the highest daily amount unlikely to cause harm in most people. A ceiling, not a goal.
- Perimenopause — the years of irregular cycles before periods stop for good.
- Adverse event report — a record that someone suspected a product was involved in a symptom. Not proof that it was.
At a Glance
- Recommended iron needs fall sharply once menstruation ends: 12 → 7 mg in Korea, 18 → 8 mg in the US, 16 → 11 mg in the EU[1][2][3].
- During perimenopause iron needs can rise before they fall, because bleeding often gets heavier first.
- Any bleeding after twelve period-free months warrants evaluation rather than a supplement[4].
- Ferritin below 15 µg/L suggests deficiency in adults; above 150 µg/L in women flags possible excess[5].
- Korean survey data link higher ferritin after menopause to metabolic syndrome criteria, without showing cause[6].
- The C282Y variant behind most Western hereditary haemochromatosis was absent in 502 Koreans tested[8].
- Digestive complaints dominate adverse event reports involving iron-named products[9].
※ This article is for general information and does not replace diagnosis, treatment, or advice from a qualified clinician. Do not start, stop, or change a supplement or medication based on it.
References
- Ministry of Health and Welfare & The Korean Nutrition Society — 2025 Dietary Reference Intakes for Koreans (KDRIs), summary tables. https://www.kns.or.kr/fileroom/fileroom_view.asp?idx=167&BoardID=Kdr · summary PDF: https://health.seoulmc.or.kr/uploadFiles/2025_%ED%95%9C%EA%B5%AD%EC%9D%B8%EC%98%81%EC%96%91%EC%86%8C%EC%84%AD%EC%B7%A8%EA%B8%B0%EC%A4%80_%ED%99%9C%EC%9A%A9.pdf
- NIH Office of Dietary Supplements — Iron: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Iron-HealthProfessional/
- EFSA NDA Panel — Scientific Opinion on Dietary Reference Values for iron. EFSA Journal 2015;13(10):4254. https://www.efsa.europa.eu/en/efsajournal/pub/4254
- Sung S, Carlson K, Abramovitz A — Postmenopausal Bleeding. StatPearls, updated 22 January 2025. https://www.ncbi.nlm.nih.gov/books/NBK562188/
- World Health Organization — WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations (2020), Table 1. https://www.who.int/publications/i/item/9789240000124 · table: https://www.ncbi.nlm.nih.gov/books/NBK569877/table/fm-ch2.tab1/
- Cho GJ, Shin JH, Yi KW, et al. — Serum ferritin levels are associated with metabolic syndrome in postmenopausal women but not in premenopausal women. Menopause 2011;18(10):1120-4. https://doi.org/10.1097/gme.0b013e318217e172
- Yun S, Nguyen HD, Park JS, Oh C, Kim MS — The association between the metabolic syndrome and iron status in pre- and postmenopausal women: KNHANES 2012. Br J Nutr 2021;127(4):630-640. https://doi.org/10.1017/S0007114521001331
- Lee JY, Yoo KH, Hahn SH — HFE gene mutation, C282Y causing hereditary hemochromatosis in Caucasian is extremely rare in Korean population. J Korean Med Sci 2000;15(2):179-82. https://doi.org/10.3346/jkms.2000.15.2.179
- openFDA — CAERS (CFSAN Adverse Event Reporting System) food event API. https://open.fda.gov/apis/food/event · query: products.name_brand:”IRON” AND consumer.gender:”Female”, counted on reactions.exact, data as of 7 July 2026